Navigation Links
Association of Clinical Research Organizations (ACRO) to Help Lead Clinical Trials Transformation Initiative
Date:5/6/2008

ACRO to collaborate with key stakeholders on efforts to enhance the clinical research enterprise

WASHINGTON, May 6 /PRNewswire-USNewswire/ -- The Association of Clinical Research Organizations (ACRO), which represents the clinical outsourcing industry to regulators, biopharmaceutical clients, policymakers, and the public in the U.S. and worldwide, today announced its leadership role in the recently formed Clinical Trial Transformation Initiative (CTTI). The goal of the CTTI is to modernize the mechanics of clinical trials and to increase their efficiency and productivity.

The CTTI was established by the U.S. Food and Drug Administration (FDA) in collaboration with Duke University as part of the FDA's Critical Path Initiative. Alberto Grignolo, Ph.D., Corporate Vice President and General Manager of PAREXEL Consulting, a business unit of PAREXEL International, will represent the association on the CTTI Executive Board, which is comprised of experts from the FDA, National Institutes of Health (NIH), academia, biopharmaceutical companies, CROs, and other organizations.

"ACRO is excited to be a part of this important effort to further enhance the clinical trial process," said ACRO Executive Director Doug Peddicord, Ph.D. "We are pleased to have an industry leader like Dr. Grignolo participating on behalf of the association to share the CRO perspective and the expertise of our members with the consortium."

"CTTI has an important charge as it looks to establish models for clinical trial innovation in areas such as study design, operating procedures, and metrics for evaluation," said Dr. Grignolo. "I look forward to representing the CRO industry and working with the wide range of stakeholders involved to help make this initiative successful for all who participate in the clinical trial enterprise, including study participants, investigators, regulators, sponsors, and CROs."

About ACRO

The Association of Clinical Research Organizations (ACRO) is the professional organization of companies whose focus is clinical research. The association provides an active voice for the CRO industry, which provides specialized services that are integral to the development of drugs, biologics, and medical devices. ACRO helps its members improve the quality, efficiency, and safety of biomedical research. For more information, please visit http://www.acrohealth.org.


'/>"/>
SOURCE Association of Clinical Research Organizations
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
2. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
3. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
4. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
5. American Fertility Association Calls for Expanded Research to Advance New Technology to Screen Embryos for Genetic Abnormalities
6. Actress and Mother Jennifer Garner Joins American Lung Association to Encourage Americans to Get an Influenza Vaccination
7. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
8. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
9. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
10. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
11. MedicAlert Foundation Joins The Alzheimers Association to Offer MedicAlert(R) + Alzheimers Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
Breaking Medicine News(10 mins):